Clinical Trial Update: Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose melphalan delivered directly into the liver, followed by an approved cancer treatment, versus approved cancer treatment alone…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: Delcath Systems Inc. | Conditions: Refractory Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING